TERF1 and cardiac hypertrophy: Therefore, in myocardial hypertrophy, tRF-Glu-CTC-013 targets and inhibits Tas1r3, thereby promoting autophagy and attenuating inflammation, myocardial hypertrophy and fibrosis (Fig. 6).